Please enable JavaScript to continue using this application.

Compare $CNTN vs $NBP | Chartloom

Compare

$CNTN vs $NBP

Canton Strategic Holdings Inc · NovaBridge Biosciences

CNTN

Canton Strategic Holdings Inc

NBP

NovaBridge Biosciences

Compare $CNTN vs $NBP

Comparing Canton Strategic Holdings Inc and NovaBridge Biosciences

CNTNCanton Strategic Holdings Inc

NBPNovaBridge Biosciences

CNTNCanton Strategic Holdings Inc

Market cap

$163M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-37.6%

52W performance

-33.6%

FCF yield

-97.9%

NBPNovaBridge Biosciences

Market cap

$161M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.3%

52W performance

-72.5%

FCF yield

-33.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTN

NBP

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

NBP

NovaBridge Biosciences

Market Cap

CNTN$163M

NBP$161M

Enterprise Value

CNTN$125M

NBP$-30M

Price

CNTN$2.11

NBP$1.40

P/E Ratio

CNTNN/A

NBPN/A

P/S Ratio

CNTN108.78x

NBP3.29x

EV/Sales

CNTN83.88x

NBP0.00x

EV/EBITDA

CNTN0.00x

NBP0.00x

P/B Ratio

CNTN0.39x

NBP0.77x

P/FCF Ratio

CNTNN/A

NBPN/A

EV/FCF

CNTN-0.79x

NBP0.55x

PEG Ratio

CNTNN/A

NBPN/A

Forward P/E (NTM)

CNTNN/A

NBPN/A

Forward P/S (NTM)

CNTNN/A

NBPN/A

Revenue (TTM)

CNTN$1M

NBP$0

Revenue Growth (YoY)

CNTNN/A

NBPN/A

Forward Rev Growth

CNTN0.0%

NBP419.8%

Gross Margin (TTM)

CNTN0.0%

NBP100.0%

Operating Margin (TTM)

CNTN0.0%

NBP0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

NBP0.0%

Net Margin (TTM)

CNTN-6559.1%

NBP0.0%

FCF Margin (TTM)

CNTN-10651.0%

NBPN/A

Net Income (TTM)

CNTN$-98M

NBP$-43M

FCF (TTM)

CNTN$-159M

NBP$-55M

EPS (TTM)

CNTN-$0.45

NBP$0.00

ROE (TTM)

CNTN-2954.0%

NBP-2091.0%

ROA (TTM)

CNTN-2342.0%

NBP-1941.0%

ROIC (TTM)

CNTN-2953.0%

NBP-2091.0%

Cash

CNTN$37M

NBP$191M

Debt

CNTN$0

NBP$0

Net Cash/Debt

CNTN$37M

NBP$191M

Current Ratio (TTM)

CNTN15.70x

NBP7.64x

Quick Ratio (TTM)

CNTN14.45x

NBP7.60x

Debt/Equity (TTM)

CNTN0.00x

NBP0.00x

Debt/Assets (TTM)

CNTN0.0%

NBP0.0%

Interest Coverage (TTM)

CNTNN/A

NBPN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

NBP0.00x

Beta

CNTN1.52

NBP1.69

52W Performance

CNTN-33.6%

NBP-72.5%

YTD Performance

CNTN-37.6%

NBP-67.3%

% from 52W High

CNTN-69.4%

NBP-79.5%

% from 52W Low

CNTN20.6%

NBP6.5%

Asset Turnover (TTM)

CNTN0.00x

NBP0.11x

FCF Yield (TTM)

CNTN-97.9%

NBP-33.9%

Earnings Yield (TTM)

CNTN-60.3%

NBP-26.8%

Dividend Yield (TTM)

CNTNN/A

NBPN/A

Rule of 40

CNTN-10,651.0

NBP0.0

EV/GP/RG

CNTNN/A

NBPN/A

Ticker research

View CNTN research View NBP research

Metric	CNTN Canton Strategic Holdings Inc	NBP NovaBridge Biosciences
Market & Valuation
Market Cap	$163M	$161M
Enterprise Value	$125M	$-30M
Price	$2.11	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	3.29x
EV/Sales	83.88x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	419.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	0.0%
Net Margin (TTM)	-6559.1%	0.0%
FCF Margin (TTM)	-10651.0%	N/A
Net Income (TTM)	$-98M	$-43M
FCF (TTM)	$-159M	$-55M
EPS (TTM)	-$0.45	$0.00
ROE (TTM)	-2954.0%	-2091.0%
ROA (TTM)	-2342.0%	-1941.0%
ROIC (TTM)	-2953.0%	-2091.0%
Financial Health
Cash	$37M	$191M
Debt	$0	$0
Net Cash/Debt	$37M	$191M
Current Ratio (TTM)	15.70x	7.64x
Quick Ratio (TTM)	14.45x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.69
52W Performance	-33.6%	-72.5%
YTD Performance	-37.6%	-67.3%
% from 52W High	-69.4%	-79.5%
% from 52W Low	20.6%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-97.9%	-33.9%
Earnings Yield (TTM)	-60.3%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View NBP research

Valuation

P/S Ratio

NBP

3.29x

CNTN

108.78x

EV/FCF

CNTN

-0.79x

NBP

0.55x

Growth & revenue

Forward Revenue Growth

NBP

419.8%

CNTN

0.0%

Profitability & performance

Gross Margin

NBP

100.0%

CNTN

0.0%

ROE

NBP

-2091.0%

CNTN

-2954.0%

FCF Yield %

NBP

-33.9%

CNTN

-97.9%

52-Week Performance

CNTN

-33.6%

NBP

-72.5%

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

NBP

NovaBridge Biosciences

Market Cap

CNTN$163M

NBP$161M

Enterprise Value

CNTN$125M

NBP$-30M

Price

CNTN$2.11

NBP$1.40

P/E Ratio

CNTNN/A

NBPN/A

P/S Ratio

CNTN108.78x

NBP3.29x

EV/Sales

CNTN83.88x

NBP0.00x

EV/EBITDA

CNTN0.00x

NBP0.00x

P/B Ratio

CNTN0.39x

NBP0.77x

P/FCF Ratio

CNTNN/A

NBPN/A

EV/FCF

CNTN-0.79x

NBP0.55x

PEG Ratio

CNTNN/A

NBPN/A

Forward P/E (NTM)

CNTNN/A

NBPN/A

Forward P/S (NTM)

CNTNN/A

NBPN/A

Revenue (TTM)

CNTN$1M

NBP$0

Revenue Growth (YoY)

CNTNN/A

NBPN/A

Forward Rev Growth

CNTN0.0%

NBP419.8%

Gross Margin (TTM)

CNTN0.0%

NBP100.0%

Operating Margin (TTM)

CNTN0.0%

NBP0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

NBP0.0%

Net Margin (TTM)

CNTN-6559.1%

NBP0.0%

FCF Margin (TTM)

CNTN-10651.0%

NBPN/A

Net Income (TTM)

CNTN$-98M

NBP$-43M

FCF (TTM)

CNTN$-159M

NBP$-55M

EPS (TTM)

CNTN-$0.45

NBP$0.00

ROE (TTM)

CNTN-2954.0%

NBP-2091.0%

ROA (TTM)

CNTN-2342.0%

NBP-1941.0%

ROIC (TTM)

CNTN-2953.0%

NBP-2091.0%

Cash

CNTN$37M

NBP$191M

Debt

CNTN$0

NBP$0

Net Cash/Debt

CNTN$37M

NBP$191M

Current Ratio (TTM)

CNTN15.70x

NBP7.64x

Quick Ratio (TTM)

CNTN14.45x

NBP7.60x

Debt/Equity (TTM)

CNTN0.00x

NBP0.00x

Debt/Assets (TTM)

CNTN0.0%

NBP0.0%

Interest Coverage (TTM)

CNTNN/A

NBPN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

NBP0.00x

Beta

CNTN1.52

NBP1.69

52W Performance

CNTN-33.6%

NBP-72.5%

YTD Performance

CNTN-37.6%

NBP-67.3%

% from 52W High

CNTN-69.4%

NBP-79.5%

% from 52W Low

CNTN20.6%

NBP6.5%

Asset Turnover (TTM)

CNTN0.00x

NBP0.11x

FCF Yield (TTM)

CNTN-97.9%

NBP-33.9%

Earnings Yield (TTM)

CNTN-60.3%

NBP-26.8%

Dividend Yield (TTM)

CNTNN/A

NBPN/A

Rule of 40

CNTN-10,651.0

NBP0.0

EV/GP/RG

CNTNN/A

NBPN/A

Ticker research

View CNTN research View NBP research

Metric	CNTN Canton Strategic Holdings Inc	NBP NovaBridge Biosciences
Market & Valuation
Market Cap	$163M	$161M
Enterprise Value	$125M	$-30M
Price	$2.11	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	3.29x
EV/Sales	83.88x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$1M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	419.8%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	0.0%
Net Margin (TTM)	-6559.1%	0.0%
FCF Margin (TTM)	-10651.0%	N/A
Net Income (TTM)	$-98M	$-43M
FCF (TTM)	$-159M	$-55M
EPS (TTM)	-$0.45	$0.00
ROE (TTM)	-2954.0%	-2091.0%
ROA (TTM)	-2342.0%	-1941.0%
ROIC (TTM)	-2953.0%	-2091.0%
Financial Health
Cash	$37M	$191M
Debt	$0	$0
Net Cash/Debt	$37M	$191M
Current Ratio (TTM)	15.70x	7.64x
Quick Ratio (TTM)	14.45x	7.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.69
52W Performance	-33.6%	-72.5%
YTD Performance	-37.6%	-67.3%
% from 52W High	-69.4%	-79.5%
% from 52W Low	20.6%	6.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-97.9%	-33.9%
Earnings Yield (TTM)	-60.3%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View NBP research